Telix Appoints Paul Schaffer as Chief Technology Officer
![]() |
MELBOURNE, Australia and INDIANAPOLIS, April 7, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that is has appointed Dr. Paul Schaffer to the newly created role of Chief Technology Officer (CTO), effective today.
Dr. Schaffer has been CTO at ARTMS Inc. (ARTMS) (acquired by Telix...
Read more: Telix Appoints Paul Schaffer as Chief Technology Officer





